A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2011
10/12/2011	CN101507804B Medicine for injury pain and its preparation technique
10/12/2011	CN101194971B Orally taken Chinese medicine for treating postpartum hyperpyrexia
10/11/2011	US8034955 triterpenoids such as 2-cyano-3,12-dioxoolean-1,9-dien-28oic acid, used for inhibiting gamma -inteferon-induced nitric oxide production in macrophages; preventing cancer, Alzheimer's disease, Parkinson's disease, inflammatory bowel diseases, and multiple sclerosis
10/11/2011	US8034954 Calcium channel antagonists
10/11/2011	US8034933 graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides
10/11/2011	US8034826 Cycloalkane[B]azaindole antagonists of prostaglandin D2 receptors
10/11/2011	US8034814 Phthalazine derivatives with angiogenesis inhibiting activity
10/11/2011	US8034810 Matrix metalloproteinase inhibitors; antiinflammatory agengs; rheumatoid arthritis, osteoarthritis; antitumor, anticarcinogenic, and antimetastasis agents; respiratory system disorders, chronic obstructive pulmonary disease, deblocking, deprotecting
10/11/2011	US8034784 Method of suppressing or reducing IL-TIF-induced inflammation, or treating associated conditions thereof, using Zcytor16
10/11/2011	US8034615 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same
10/11/2011	US8034379 Hydrophilic gel foaming matrix; cellulose ethers
10/11/2011	US8034374 Patch containing nonsteroidal anti-inflammatory and analgesic agent
10/11/2011	US8034343 Methods of treating inflammatory disorders of the lungs
10/11/2011	CA2554070C Macrolides with antiinflammatory activity
10/11/2011	CA2506930C Dosage forms containing a proton pump inhibitor, a nsaid, and a buffer
10/11/2011	CA2494100C Pyrazole compositions useful as inhibitors of gsk-3
10/11/2011	CA2488934C Aryl oxime derivatives as phosphodiesterase iv inhibitors for the treatment of diseases
10/11/2011	CA2476405C Compositions and methods for treatment of microbial infections
10/11/2011	CA2472479C Deazapurines and uses thereof
10/11/2011	CA2424734C Nanoparticles comprising a metallic or semiconductor core which is covalently bound to a plurality of carbohydrate ligands
10/11/2011	CA2416475C Medicinal uses of mu-opioid receptor agonists
10/11/2011	CA2394862C Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder
10/11/2011	CA2390472C Anti-inflammatory actions of cytochrome p450 epoxygenase-derived eicosanoids
10/06/2011	WO2011123751A2 Heterocyclic compounds and their uses
10/06/2011	WO2011123482A1 Purine compounds used as cb2 agonists
10/06/2011	WO2011123232A1 Cgrp receptor antagonist
10/06/2011	WO2011122620A1 Pharmaceutical preparation comprising phenylalanine derivative
10/06/2011	WO2011122619A1 Phenylalanine derivative salt crystal
10/06/2011	WO2011121505A1 Cytokine inhibitors
10/06/2011	WO2011121366A1 Pyrazole p38 map kinase inhibitors
10/06/2011	WO2011121160A1 Pharmaceutical formulation based on ibuprofen and codeine having having improved stability
10/06/2011	WO2011121137A1 Novel nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disorders
10/06/2011	WO2011120604A1 "trpv1 vanilloid receptor antagonists with a bicyclic portion"
10/06/2011	WO2011120082A1 A method of modulating protein 14-3-3 functionality by facilitating or inhibiting phosphorylation
10/06/2011	WO2011089618A3 Drug-eluting insert able medical device for treating acute myocardial infarction, thrombus containing lesions and saphenous- vein graft lesions
10/06/2011	WO2011035143A4 Methods and compositions for inhibiting rho-mediated diseases and conditions
10/06/2011	WO2010103279A8 Bis aromatic compounds for use as ltc4 synthase inhibitors
10/06/2011	US20110247087 Regulation of endogenous gene expression in cells using zinc finger proteins
10/06/2011	US20110245501 Substituted Tetracycline Compounds as Synergistic Antifungal Agents
10/06/2011	US20110245337 Method for enhancing the dna repair process, treating disorders associated with the dna repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering purified quinic acid and/or carboxy alkyl ester
10/06/2011	US20110245335 New inhibitors for treating diseases associated with an excess transport of hyaluronan
10/06/2011	US20110245333 Identification of free-b-ring flavonoids as potent cox-2 inhibitors
10/06/2011	US20110245332 Injectable formulations of taxanes for cad treatment
10/06/2011	US20110245323 RIG-Like Helicase Innate Immunity Inhibits VEGF-Induced Tissue Responses
10/06/2011	US20110245322 Methods for identifying and compounds useful for increasing the functional activity and cell surface expression of cf-associated mutant cystic fibrosis transmembrane conductance regulator
10/06/2011	US20110245291 Tricyclic delta-opioid modulators
10/06/2011	US20110245286 Treatment of inflammation using alpha 7 receptor-binding agonists
10/06/2011	US20110245270 Nicotinic receptor agonists for the treatment of inflammatory diseases
10/06/2011	US20110245257 Heterocyclic compounds and their uses
10/06/2011	US20110245255 Purine compounds
10/06/2011	US20110245251 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
10/06/2011	US20110245248 Isoquinoline derivatives
10/06/2011	US20110245245 Methods of treatment comprising the administration of heteroaryl compounds
10/06/2011	US20110245230 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
10/06/2011	US20110245225 Quinazolinamide derivatives
10/06/2011	US20110245222 Methods for Using Carboxamide, Sulfonamide and Amine Compounds
10/06/2011	US20110245221 Aryl isoxazole compounds with antitumoural activities
10/06/2011	US20110245220 Compounds and compositions as modulators of gpr119 activity
10/06/2011	US20110245214 Organic compounds
10/06/2011	US20110245213 Treatment
10/06/2011	US20110245209 Pyridopyrimidine derivatives and methods of use thereof
10/06/2011	US20110245208 Compositions and methods for the treatment of somatosensory disorders
10/06/2011	US20110245206 Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives
10/06/2011	US20110245202 Pharmaceutical composition for the treatment of rhinitis
10/06/2011	US20110245199 Sulfated Depolymerized Derivatives of Expolysaccharides (Eps) from Mesophilic Marine Bacteria, Method for Preparing the Same, and Uses Thereof in Tissue Regeneration
10/06/2011	US20110245197 Hypersulfated glucopyranosides
10/06/2011	US20110245196 Novel sulfated oligosaccharide derivatives
10/06/2011	US20110245186 Recombinant e-selectin made in insect cells
10/06/2011	US20110245180 Modified Peptide that reduces pain in peripheral neuropathy
10/06/2011	US20110245168 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
10/06/2011	US20110245159 Salts, Solvates and Pharmaceutical Compositions of Macrocyclic Ghrelin Receptor Agonists and Methods of Using the Same
10/06/2011	US20110245154 Methods and Compositions for Treating Viral or Virally-Induced Conditions
10/06/2011	US20110245149 Methods to prevent and treat diseases
10/06/2011	US20110244053 Use a goat serum for veterinary treatment
10/06/2011	US20110244039 Absorbable solid compositions for topical treatment of oral mucosal disorders
10/06/2011	US20110244038 Berry preparations and extracts
10/06/2011	US20110244002 Mesoporous material excipients for poorly aqueous soluble ingredients
10/06/2011	US20110243999 Methods and compositions for the treatment of ocular disorders
10/06/2011	US20110243985 Self-adhesive matrix system comprising a styrene block copolymer
10/06/2011	US20110243964 Treatment of orthopedic conditions
10/06/2011	US20110243960 Methods and compositions for treating p. acnes
10/06/2011	US20110243955 Antibody and uses thereof
10/06/2011	US20110243951 Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins
10/06/2011	US20110243945 Anti-Inflammatory Agents
10/06/2011	US20110243938 Methods to Reduce B-Helper T Cells to Treat Autoimmune Diseases
10/06/2011	US20110243936 TNFalpha-NEUTRALIZING ANTIBODIES
10/06/2011	US20110243932 Anti-cd40 antibodies
10/06/2011	US20110243930 Compositions and methods for the treatment of immune related diseases
10/06/2011	US20110243923 Organic compounds
10/06/2011	US20110243893 Markers for determination of patient responsiveness
10/06/2011	US20110243881 Biocompatible polymers, process for their preparation and compositions containing them
10/06/2011	US20110243856 Permeable Mixtures, Methods and Compositions for the Skin
10/06/2011	US20110243842 Mammalian receptor proteins; related reagents and methods
10/06/2011	DE102011006425A1 Pharmaceutical composition, useful for treating and/or preventing e.g. Parkinson's disease, dementia, neuropathic pain, retinitis pigmentosa, multiple sclerosis and amyotrophic lateral sclerosis, comprises flupirtine and N-acetylcysteine
10/06/2011	CA2795177A1 Method of treating inflammation
10/06/2011	CA2795006A1 Purine compounds used as cb2 agonists
10/06/2011	CA2794950A1 Cgrp receptor antagonist
10/06/2011	CA2794773A1 Trpv1 vanilloid receptor antagonists with a bicyclic portion
10/06/2011	CA2794676A1 Cytokine inhibitors
10/06/2011	CA2794594A1 Cosmetic and pharmaceutical composition comprising n-acetylglucosamine-6-phosphate

1 ... 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 ... 1272